Also trades as: RAONF (OTC) · $vol 0M
RAC.AX ASX
Race Oncology Limited
1W: -6.3%
1M: -10.3%
3M: -12.7%
YTD: -21.6%
1Y: +57.4%
3Y: +93.0%
5Y: -40.9%
A$1.89 ($1.32)
-0.03 (-1.46%)
Weekly Expected Move ±5.3%
A$2
A$2
A$2
A$2
A$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$8M
-80.3% ▼
Capital Expenditures
$4K
-122533.3% ▼
Free Cash Flow
-$8M
-80.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$21M
+685.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$11M | -$10M | -$14M | -$5M | -$11M |
| Depreciation & Amort. | $281K | $281K | $281K | $281K | $281K |
| Stock-Based Comp. | $3M | $591K | $1M | $1M | $0 |
| Change in Working Capital | $2M | -$2M | $2M | -$1M | -$88K |
| Other Non-Cash Items | $3M | $3M | $681K | -$448K | $3M |
| Operating Cash Flow | -$6M | -$11M | -$10M | -$5M | -$8M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$4K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $532 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $8M | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $8M | $0 | $0 | -$3K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | -$463K | -$1M | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $31M | -$1M | $5M | $1M | $29M |
| Net Change in Cash | -$3M | -$4M | -$4M | -$4M | $21M |
| Cash End of Period | $6M | $2M | $17M | $14M | $34M |
| Free Cash Flow | -$6M | -$11M | -$10M | -$5M | -$8M |